Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

89 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation: results on health-related quality of life and symptom burden. The MANTRA-PAF trial.
Walfridsson H, Walfridsson U, Nielsen JC, Johannessen A, Raatikainen P, Janzon M, Levin LA, Aronsson M, Hindricks G, Kongstad O, Pehrson S, Englund A, Hartikainen J, Mortensen LS, Hansen PS. Walfridsson H, et al. Among authors: raatikainen p. Europace. 2015 Feb;17(2):215-21. doi: 10.1093/europace/euu342. Epub 2015 Jan 6. Europace. 2015. PMID: 25567068 Clinical Trial.
Long-term efficacy of catheter ablation as first-line therapy for paroxysmal atrial fibrillation: 5-year outcome in a randomised clinical trial.
Nielsen JC, Johannessen A, Raatikainen P, Hindricks G, Walfridsson H, Pehrson SM, Englund A, Hartikainen J, Mortensen LS, Hansen PS; MANTRA-PAF Investigators. Nielsen JC, et al. Among authors: raatikainen p. Heart. 2017 Mar;103(5):368-376. doi: 10.1136/heartjnl-2016-309781. Epub 2016 Aug 26. Heart. 2017. PMID: 27566295 Clinical Trial.
Higher burden of supraventricular ectopic complexes early after catheter ablation for atrial fibrillation is associated with increased risk of recurrent atrial fibrillation.
Alhede C, Johannessen A, Dixen U, Jensen JS, Raatikainen P, Hindricks G, Walfridsson H, Kongstad O, Pehrson S, Englund A, Hartikainen J, Hansen PS, Nielsen JC, Jons C. Alhede C, et al. Among authors: raatikainen p. Europace. 2018 Jan 1;20(1):50-57. doi: 10.1093/europace/euw329. Europace. 2018. PMID: 28011799 Clinical Trial.
Antiarrhythmic medication is superior to catheter ablation in suppressing supraventricular ectopic complexes in patients with atrial fibrillation.
Alhede C, Lauridsen TK, Johannessen A, Dixen U, Jensen JS, Raatikainen P, Hindricks G, Walfridsson H, Kongstad O, Pehrson S, Englund A, Hartikainen J, Hansen PS, Nielsen JC, Jons C. Alhede C, et al. Among authors: raatikainen p. Int J Cardiol. 2017 Oct 1;244:186-191. doi: 10.1016/j.ijcard.2017.05.028. Epub 2017 May 10. Int J Cardiol. 2017. PMID: 28506548 Clinical Trial.
The impact of supraventricular ectopic complexes in different age groups and risk of recurrent atrial fibrillation after antiarrhythmic medication or catheter ablation.
Alhede C, Lauridsen TK, Johannessen A, Dixen U, Jensen JS, Raatikainen P, Hindricks G, Walfridsson H, Kongstad O, Pehrson S, Englund A, Hartikainen J, Hansen PS, Nielsen JC, Jons C. Alhede C, et al. Among authors: raatikainen p. Int J Cardiol. 2018 Jan 1;250:122-127. doi: 10.1016/j.ijcard.2017.09.208. Epub 2017 Oct 9. Int J Cardiol. 2018. PMID: 29050922 Clinical Trial.
The Medical ANtiarrhythmic Treatment or Radiofrequency Ablation in Paroxysmal Atrial Fibrillation (MANTRA-PAF) trial: clinical rationale, study design, and implementation.
Jons C, Hansen PS, Johannessen A, Hindricks G, Raatikainen P, Kongstad O, Walfridsson H, Pehrson S, Almroth H, Hartikainen J, Petersen AK, Mortensen LS, Nielsen JC; MANTRA-PAF Investigators. Jons C, et al. Among authors: raatikainen p. Europace. 2009 Jul;11(7):917-23. doi: 10.1093/europace/eup122. Epub 2009 May 15. Europace. 2009. PMID: 19447807 Clinical Trial.
Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation.
Cosedis Nielsen J, Johannessen A, Raatikainen P, Hindricks G, Walfridsson H, Kongstad O, Pehrson S, Englund A, Hartikainen J, Mortensen LS, Hansen PS. Cosedis Nielsen J, et al. Among authors: raatikainen p. N Engl J Med. 2012 Oct 25;367(17):1587-95. doi: 10.1056/NEJMoa1113566. N Engl J Med. 2012. PMID: 23094720 Free article. Clinical Trial.
The cost-effectiveness of radiofrequency catheter ablation as first-line treatment for paroxysmal atrial fibrillation: results from a MANTRA-PAF substudy.
Aronsson M, Walfridsson H, Janzon M, Walfridsson U, Nielsen JC, Hansen PS, Johannessen A, Raatikainen P, Hindricks G, Kongstad O, Pehrson S, Englund A, Hartikainen J, Mortensen LS, Levin LÅ. Aronsson M, et al. Among authors: raatikainen p. Europace. 2015 Jan;17(1):48-55. doi: 10.1093/europace/euu188. Epub 2014 Oct 23. Europace. 2015. PMID: 25341739 Free article. Clinical Trial.
A randomized invasive cardiac electrophysiology study of the combined ion channel blocker AZD1305 in patients after catheter ablation of atrial flutter.
Toivonen L, Raatikainen P, Walfridsson H, Englund A, Hegbom F, Anfinsen OG, Gjesdal K, Pehrson S, Johansson S, Frison L, Berggren AR, Edvardsson N. Toivonen L, et al. Among authors: raatikainen p. J Cardiovasc Pharmacol. 2010 Sep;56(3):300-8. doi: 10.1097/FJC.0b013e3181ed0859. J Cardiovasc Pharmacol. 2010. PMID: 20588189 Clinical Trial.
Contemporary management of patients undergoing atrial fibrillation ablation: in-hospital and 1-year follow-up findings from the ESC-EHRA atrial fibrillation ablation long-term registry.
Arbelo E, Brugada J, Blomström-Lundqvist C, Laroche C, Kautzner J, Pokushalov E, Raatikainen P, Efremidis M, Hindricks G, Barrera A, Maggioni A, Tavazzi L, Dagres N; on the behalf of the ESC-EHRA Atrial Fibrillation Ablation Long-term Registry Investigators. Arbelo E, et al. Among authors: raatikainen p. Eur Heart J. 2017 May 1;38(17):1303-1316. doi: 10.1093/eurheartj/ehw564. Eur Heart J. 2017. PMID: 28104790 Free article.
89 results